McDermott Wendy
Insider CIK 1902760 · LXRX VP, Human Resources
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2026-02-28 | 2026-03-03 | 27,697 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2026-02-28 | 2026-03-03 | 144,393 | — | $0 | 288,787 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2026-02-28 | 2026-03-03 | 52,316 | — | $0 | 52,317 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2026-02-28 | 2026-03-03 | 68,107 | $1.47 | $100.1K | 277,945 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2026-02-28 | 2026-03-03 | 144,393 | — | $0 | 346,052 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2026-02-28 | 2026-03-03 | 27,697 | — | $0 | 149,343 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2026-02-28 | 2026-03-03 | 52,316 | — | $0 | 201,659 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2026-02-12 | 2026-02-17 | 250,200 | — | $0 | 250,200 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2026-02-12 | 2026-02-17 | 375,300 | — | $0 | 375,300 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2025-02-28 | 2025-03-03 | 52,317 | — | $0 | 104,633 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2025-02-28 | 2025-03-03 | 18,943 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2025-02-28 | 2025-03-03 | 27,696 | — | $0 | 27,697 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2025-02-28 | 2025-03-03 | 52,317 | — | $0 | 151,650 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2025-02-28 | 2025-03-03 | 30,004 | $0.67 | $20.1K | 121,646 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2025-02-28 | 2025-03-03 | 27,696 | — | $0 | 99,333 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2025-02-28 | 2025-03-03 | 18,943 | — | $0 | 71,637 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-02-13 | 2025-02-18 | 433,180 | — | $0 | 433,180 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-02-13 | 2025-02-18 | 649,780 | — | $0 | 649,780 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 18,944 | — | $0 | 18,943 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 27,697 | — | $0 | 55,393 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 18,944 | — | $0 | 47,422 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 27,697 | — | $0 | 75,119 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2024-02-28 | 2024-02-29 | 22,425 | $2.62 | $58.8K | 52,694 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-02-08 | 2024-02-12 | 156,950 | — | $0 | 156,950 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-02-08 | 2024-02-12 | 156,950 | — | $0 | 156,950 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2023-08-04 | 2023-08-07 | 6,000 | $1.84 | $11.0K | 28,478 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2023-06-23 | 2023-06-27 | 10,000 | $2.43 | $24.3K | 22,478 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-02-28 | 2023-03-01 | 18,943 | — | $0 | 37,887 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2023-02-28 | 2023-03-01 | 6,465 | $2.17 | $14.0K | 12,478 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-02-28 | 2023-03-01 | 18,943 | — | $0 | 18,943 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2023-02-09 | 2023-02-13 | 83,090 | — | $0 | 83,090 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2023-02-09 | 2023-02-13 | 249,280 | — | $0 | 249,280 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-02-10 | 2022-02-14 | 56,830 | — | $0 | 56,830 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-02-10 | 2022-02-14 | 170,500 | — | $0 | 170,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-01-03 | 2022-01-04 | 85,185 | — | $0 | 85,185 | SEC↗ |